BioSpace News Archive

The leading global healthcare technology company, CompuGroup Medical (CGM), assisted Lenco Diagnostic Laboratory (Lenco) with the launch of its successful COVID-19 testing program on March 19

Aletha Health is pleased to introduce their latest patent pending product, the Hip Hook. The new product is the world’s first tool designed to specifically release tension in the iliacus muscle.

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will present at the Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 9:00 a.m. ET. The live audio cast will be available at https://www.webcaster4.com/Webcast/Page/2513/37778 and it will be accessible for replay for 90 days following the conference. The company’s management team, incl

Aytu BioScience, Inc. (NASDAQ:AYTU) (the “Company”), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that it will reschedule its fourth quarter and FY 2020 conference call, previously scheduled for Thursday, September 24 at 4:30pm ET.

Gilead Sciences, Inc. announced the pricing of senior unsecured notes in an aggregate principal amount of $7.25 billion, in an underwritten, registered public offering, consisting of seven tranches

Zogenix, Inc. announced the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Today, xCures Inc., together with a confidential partner, is pleased to announce their launch of a medical food clinical trial. This study, to be led by Jennifer R. Grandis , M.D., aims to characterize a highly engineered medical food formulation as a foundation or component for treatment of patients with advanced pancreatic duc

Magnolia Medical Technologies, Inc. today announced that the company was selected as the Innovative Technology Supplier of the Year by Vizient Inc. The award was presented in a virtual Awards Ceremony as part of the 2020 Vizient Connections Education Summit.

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency’s most prominent safety warning, and requiring class-wide labeling

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that positive results from the two pivotal Phase III CAMP ( C antharidin A pplication in M olluscum P atients [CAMP-1 and CAMP-2]) studies evaluating the safety and efficacy of VP-102 in children and adults with molluscum were published in the Journal of the